Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder

被引:21
|
作者
Komulainen, Emma [1 ,2 ]
Heikkila, Roope [1 ,2 ]
Nummenmaa, Lauri [3 ,4 ]
Raij, Tuukka T. [1 ,2 ,5 ,6 ]
Harmer, Catherine J. [7 ]
Isometsa, Erkki [1 ,2 ]
Ekelund, Jesper [8 ,9 ]
机构
[1] Univ Helsinki, Helsinki, Finland
[2] Helsinki Univ Hosp, Psychiat, Helsinki, Finland
[3] Univ Turku, Turku PET Ctr, Turku, Finland
[4] Univ Turku, Dept Psychol, Turku, Finland
[5] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland
[6] Aalto Univ, Aalto NeuroImaging, Espoo, Finland
[7] Univ Dept Psychiat, Oxford, England
[8] Univ Turku, Turku, Finland
[9] Turku Univ Hosp, Turku, Finland
基金
芬兰科学院;
关键词
Depression; Antidepressant; Escitalopram; fMRI; Emotion; Self-referential processing; MEDIAL PREFRONTAL CORTEX; DEFAULT-MODE NETWORK; HEALTHY-VOLUNTEERS; BRAIN; METAANALYSIS; RECOGNITION; INVENTORY; RESPONSES; BIAS; MRI;
D O I
10.1016/j.jad.2018.04.096
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Increased self-focus and negative self-concept play an important role in depression. Antidepressants influence self-referential processing in healthy volunteers, but their function in self-processing of depressed patients remains unknown. Methods: Thirty-two depressed patients were randomly allocated to receive either escitalopram 10 mg or placebo for one week. After one week, neural responses to positive and negative self-referential adjectives and neutral control stimuli were assessed with functional magnetic resonance imaging. A group of matched healthy volunteers served as a control group. Results: Escitalopram decreased responses of medial fronto-parietal regions to self-referential words relative to non-emotional control stimuli, driven by increased responses to the control condition. Escitalopram also increased responses in the pre-defined region of the medial prefrontal cortex (MPFC) and the anterior cingulate cortex (ACC) to positive relative to negative words. Importantly, the changes in neural responses occurred before any effect on depressive symptoms, implying a direct effect of escitalopram. Furthermore, the placebo group had decreased responses of the MPFC and the ACC to positive self-referential processing relative to the matched healthy controls. However, neural responses of the escitalopram group and the healthy unmedicated controls were similar. Limitations: Differences between the groups in self-reported depression symptoms and personality traits may have influenced the results. Conclusion: One-week treatment with escitalopram normalized aberrant self-referential processing in depressed patients, shifting the focus from the self to the external environment and potentiating positive self-referential processing. This may be an important factor in mechanism of action of antidepressants.
引用
收藏
页码:222 / 229
页数:8
相关论文
共 50 条
  • [31] Childhood Maltreatment, Negative Self-Referential Processing, and Depressive Symptoms During Stress
    Jopling, Ellen
    Tracy, Alison
    LeMoult, Joelle
    PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT, 2020, 13 : 79 - 87
  • [32] Short-term cerebral blood flow variability in major depressive disorder
    Duschek, Stefan
    Hoffmann, Alexandra
    Reyes del Paso, Gustavo A.
    Montoro, Casandra, I
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 282 : 1120 - 1124
  • [33] Impaired Self-Referential Cognitive Processing in Bipolar Disorder: A Functional Connectivity Analysis
    Zhang, Jian
    Liu, Tiantian
    Shi, Zhongyan
    Tan, Shuping
    Suo, Dingjie
    Dai, Chunyang
    Wang, Li
    Wu, Jinglong
    Funahashi, Shintaro
    Liu, Miaomiao
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [34] Neural Correlates of Self-referential Processing and Their Clinical Implications in Social Anxiety Disorder
    Yoon, Hyung-Jun
    Seo, Eun Hyun
    Kim, Jae-Jin
    Choo, Il Han
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2019, 17 (01) : 12 - 24
  • [35] Brain-behavioral correlates of self-referential processing in social anxiety disorder
    Goldin, Philippe R.
    Hakimi, Shabnam
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 183S - 183S
  • [36] Escitalopram in the treatment of major depressive disorder in adolescent patientsProfile report
    Lily P. H. Yang
    Lesley J. Scott
    CNS Drugs, 2010, 24 : 621 - 623
  • [37] Venlafaxine XR versus escitalopram treatment of major depressive disorder
    Zarra, J
    Schmidt, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S394 - S395
  • [38] Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder
    Soares, Claudio N.
    Thase, Michael E.
    Clayton, Anita
    Guico-Pabia, Christine J.
    Focht, Kristen
    Jiang, Qin
    Kornstein, Susan G.
    Ninan, Phil
    Kane, Cecelia P.
    Cohen, Lee S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (04): : 700 - 711
  • [39] Escitalopram versus venlafaxine XR in the treatment of major depressive disorder
    Montgomery, S.
    Andersen, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S233
  • [40] Effect of short-term escitalopram treatment on neural activation during emotional processing
    Maron, Eduard
    Wall, Matt
    Norbury, Ray
    Godlewska, Beata
    Terbeck, Sylvia
    Cowen, Philip
    Matthews, Paul
    Nutt, David J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 33 - 39